E-LIB Suche - Ergebnisse für: Gordon, Nicolas

1

The circadian cryptochrome, CRY1, is a pro-tumorigenic fact..:

Shafi, Ayesha A. ; McNair, Chris M. ; McCann, Jennifer J....
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

2

Phase I/Ib study of olaparib and carboplatin in heavily pre..:

Lampert, Erika J. ; Hays, John L. ; Kohn, Elise C....
Oncotarget. 10 (2019) 30 - p. 2855-2868 , 2019

Link: https://doi.org/10.18632..

3

PARP‐1 regulates DNA repair factor availability:

Schiewer, Matthew J ; Mandigo, Amy C ; Gordon, Nicolas...
EMBO Molecular Medicine. 10 (2018) 12 - p. , 2018

Link: https://doi.org/10.15252..

4

Phase I/Ib study of olaparib and carboplatin in women with ..:

Lee, Jung-Min ; Hays, John L. ; Chiou, Victoria L....
Oncotarget. 8 (2017) 45 - p. 79175-79187 , 2017

Link: https://doi.org/10.18632..

5

Development of a multiparameter flow cytometric assay as a ..:

Lee, Jung-Min ; Gordon, Nicolas ; Trepel, Jane B...
Journal of Translational Medicine. 13 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..

6

Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BR..:

Lee, Jung-Min ; Hays, John L. ; Annunziata, Christina M....
JNCI: Journal of the National Cancer Institute. 106 (2014) 6 - p. , 2014

Link: https://doi.org/10.1093/..

7

PARP inhibition and pharmacological ascorbate demonstrate s..:

Gordon, Nicolas ; Gallagher, Peter T ; Neupane, Neermala Poudel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055378/. , 2023

Link: http://www.ncbi.nlm.nih...

8

RB/E2F1 as a master regulator of cancer cell metabolism in ..:

Mandigo, Amy C ; Yuan, Wei ; Xu, Kexin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419081/. , 2021

Link: http://www.ncbi.nlm.nih...

9

The circadian cryptochrome, CRY1, is a pro-tumorigenic fact..:

Shafi, Ayesha A ; McNair, Chris M ; McCann, Jennifer J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810852/. , 2021

Link: http://www.ncbi.nlm.nih...

10

The circadian cryptochrome, CRY1, is a pro-tumorigenic fact..:

Shafi, Ayesha A ; McNair, Chris M ; McCann, Jennifer J...
https://jdc.jefferson.edu/cbfp/173. , 2021

Link: https://jdc.jefferson.ed..

11

Pleiotropic impact of DNA-PK in cancer and implications for..:

Dylgjeri, Emanuela ; McNair, Christopher ; Goodwin, Jonathan F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744985/. , 2019

Link: http://www.ncbi.nlm.nih...

12

PARP-1 regulates DNA repair factor availability:

Schiewer, M J ; Mandigo, Amy C ; Gordon, Nicolas...
https://jdc.jefferson.edu/cbfp/145. , 2018

Link: https://jdc.jefferson.ed..

13

Sequence-specific pharmacokinetic and pharmacodynamic phase..:

Lee, Jung-Min ; Peer, Cody J ; Yu, Minshu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354956/. , 2016

Link: http://www.ncbi.nlm.nih...

14

Development of a multiparameter flow cytometric assay as a ..:

Lee, Jung-Min ; Gordon, Nicolas ; Trepel, Jane B...
http://www.translational-medicine.com/content/13/1/239. , 2015

Link: http://www.translational..

15

Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BR..:

Lee, Jung-Min ; Hays, John L ; Annunziata, Christina M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049120/. , 2014

Link: http://www.ncbi.nlm.nih...